On consolidated basis
Quarter ended September 2024 compared with Quarter ended September 2023.
Net sales (including other operating income) of Apollo Hospitals Enterprise has increased 15.32% to Rs 5589.3 crore. Sales of Healthcare Services segment has gone up 13.82% to Rs 2,920.40 crore (accounting for 52.08% of total sales). Sales of Apollo Digital 24/7 segment rose 544.33% to Rs 2,282.20 crore (accounting for 40.70% of total sales). Sales of others segment has gone down 0.00% to Rs 1.20 crore (accounting for 0.02% of total sales). Inter-segment sales came down from Rs 19.80 crore to Rs 18.40 crore. Profit before interest, tax and other unallocable items (PBIT) has jumped 35.96% to Rs 631.00 crore. PBIT of Healthcare Services segment rose 12.24% to Rs 581.30 crore (accounting for 92.12% of total PBIT). PBIT of Apollo Digital 24/7 segment rose 1,196.67% to Rs 38.90 crore (accounting for 6.16% of total PBIT). PBIT of others segment rose 83.93% to Rs -0.90 crore (accounting for -0.14% of total PBIT). PBIT margin of Healthcare Services segment fell from 20.18% to 19.90%. PBIT margin of Apollo Digital 24/7 segment rose from 0.85% to 1.70%. PBIT margin of others segment rose from negative 466.67% to negative 75.00%. Overall PBIT margin rose from 9.54% to 11.25%. Operating profit margin has jumped from 12.95% to 14.59%, leading to 29.96% rise in operating profit to Rs 815.50 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 13.01% to 13.32%. Purchase of finished goods cost fell from 37.86% to 37.78%. Employee cost decreased from 13.25% to 12.53%. Other expenses fell from 22.97% to 21.77%. Other income rose 72.07% to Rs 38.2 crore. PBIDT rose 31.40% to Rs 853.7 crore. Provision for interest rose 5.57% to Rs 117.5 crore. Loan funds rose to Rs 7,371.00 crore as of 30 September 2024 from Rs 4,888.90 crore as of 30 September 2023. Inventories rose to Rs 448.20 crore as of 30 September 2024 from Rs 423.40 crore as of 30 September 2023. Sundry debtors were higher at Rs 2,880.40 crore as of 30 September 2024 compared to Rs 2,399.90 crore as of 30 September 2023. Cash and bank balance rose to Rs 2,210.30 crore as of 30 September 2024 from Rs 869.00 crore as of 30 September 2023. Investments rose to Rs 1,011.50 crore as of 30 September 2024 from Rs 852.80 crore as of 30 September 2023 . PBDT rose 36.74% to Rs 736.2 crore. Provision for depreciation rose 12.91% to Rs 184.5 crore. Fixed assets increased to Rs 10,230.70 crore as of 30 September 2024 from Rs 8,502.50 crore as of 30 September 2023. Intangible assets declined from Rs 1,118.40 crore to Rs 1,012.30 crore. Profit before tax grew 47.12% to Rs 551.70 crore. Share of profit/loss was 171.43% higher at Rs 5.7 crore. Provision for tax was expense of Rs 161.7 crore, compared to Rs 130.2 crore. Effective tax rate was 29.01% compared to 34.35%. Minority interest increased 6.29% to Rs 16.90 crore. Net profit attributable to owners of the company increased 62.64% to Rs 378.80 crore. Equity capital stood at Rs 71.90 crore as of 30 September 2024 to Rs 71.90 crore as of 30 September 2023. Per share face Value remained same at Rs 5.00. Promoters’ stake was 29.33% as of 30 September 2024 ,compared to 29.33% as of 30 September 2023 . Promoters pledged stake was 13.99% as of 30 September 2024 ,compared to 16.09% as of 30 September 2023 . For year-to-date (YTD) results analysis.
Net sales (including other operating income) of Apollo Hospitals Enterprise has increased 15.22% to Rs 10674.9 crore. Sales of Healthcare Services segment has gone up 14.30% to Rs 5,574.10 crore (accounting for 52.04% of total sales). Sales of Apollo Digital 24/7 segment rose 548.48% to Rs 4,364.30 crore (accounting for 40.75% of total sales). Sales of others segment has gone down 0.00% to Rs 2.40 crore (accounting for 0.02% of total sales). Inter-segment sales came down from Rs 38.00 crore to Rs 35.90 crore. Profit before interest, tax and other unallocable items (PBIT) has jumped 39.99% to Rs 1,128.70 crore. PBIT of Healthcare Services segment rose 13.94% to Rs 1,071.50 crore (accounting for 94.93% of total PBIT). PBIT of Apollo Digital 24/7 reported profit of Rs 46.10 crore compared to loss of Rs 7.20 crore. PBIT of others segment rose 52.86% to Rs -3.30 crore (accounting for -0.29% of total PBIT). PBIT margin of Healthcare Services segment fell from 19.28% to 19.22%. PBIT margin of Apollo Digital 24/7 segment rose from negative 1.07% to 1.06%. PBIT margin of others segment rose from negative 291.67% to negative 137.50%. Overall PBIT margin rose from 8.67% to 10.54%. Operating profit margin has jumped from 12.27% to 13.96%, leading to 31.16% rise in operating profit to Rs 1,490.60 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 13.08% to 13.47%. Purchase of finished goods cost fell from 38.01% to 37.76%. Employee cost decreased from 13.32% to 12.75%. Other expenses fell from 23.34% to 22.02%. Other income rose 49.60% to Rs 75.4 crore. PBIDT rose 31.94% to Rs 1566 crore. Provision for interest rose 7.54% to Rs 233.9 crore. Loan funds rose to Rs 7,371.00 crore as of 30 September 2024 from Rs 4,888.90 crore as of 30 September 2023. Inventories rose to Rs 448.20 crore as of 30 September 2024 from Rs 423.40 crore as of 30 September 2023. Sundry debtors were higher at Rs 2,880.40 crore as of 30 September 2024 compared to Rs 2,399.90 crore as of 30 September 2023. Cash and bank balance rose to Rs 2,210.30 crore as of 30 September 2024 from Rs 869.00 crore as of 30 September 2023. Investments rose to Rs 1,011.50 crore as of 30 September 2024 from Rs 852.80 crore as of 30 September 2023 . PBDT rose 37.41% to Rs 1332.1 crore. Provision for depreciation rose 9.57% to Rs 361.9 crore. Fixed assets increased to Rs 10,230.70 crore as of 30 September 2024 from Rs 8,502.50 crore as of 30 September 2023. Intangible assets declined from Rs 1,118.40 crore to Rs 1,012.30 crore. Profit before tax grew 51.81% to Rs 970.20 crore. Share of profit/loss was 115% higher at Rs 17.2 crore. Provision for tax was expense of Rs 276.2 crore, compared to Rs 226.8 crore. Effective tax rate was 27.97% compared to 34.95%.Minority interest increased 19.82% to Rs 27.20 crore. Net profit attributable to owners of the company increased 71.21% to Rs 684.00 crore. Equity capital stood at Rs 71.90 crore as of 30 September 2024 to Rs 71.90 crore as of 30 September 2023. Per share face Value remained same at Rs 5.00. Promoters’ stake was 29.33% as of 30 September 2024 ,compared to 29.33% as of 30 September 2023 . Promoters pledged stake was 13.99% as of 30 September 2024 ,compared to 16.09% as of 30 September 2023 . Cash flow from operating activities decreased to Rs 686.50 crore for YTD ended September 2024 from Rs 960.30 crore for YTD ended September 2023.
Full year results analysis.
Net sales (including other operating income) of Apollo Hospitals Enterprise has increased 14.73% to Rs 19059.2 crore. Sales of Healthcare Services segment has gone up 13.68% to Rs 9,939.20 crore (accounting for 51.94% of total sales). Sales of Apollo Digital 24/7 segment rose 10.82% to Rs 1,364.30 crore (accounting for 7.13% of total sales). Sales of others segment has gone down 0.00% to Rs 4.70 crore (accounting for 0.02% of total sales). Sales of segment has gone up 16.74% to Rs 7,826.90 crore (accounting for 40.90% of total sales). Inter-segment sales rose Rs 70.90 crore to Rs 75.90 crore. Profit before interest, tax and other unallocable items (PBIT) has jumped 18.79% to Rs 1,703.70 crore. PBIT of Healthcare Services segment rose 10.47% to Rs 1,846.40 crore (accounting for 108.38% of total PBIT). PBIT of Apollo Digital 24/7 reported loss of Rs 1.50 crore compared to profit of Rs 20.00 crore. PBIT of others segment rose 3.74% to Rs -10.30 crore (accounting for -0.60% of total PBIT). PBIT of segment rose 46.90% to Rs -130.90 crore (accounting for -7.68% of total PBIT). PBIT margin of Healthcare Services segment fell from 19.12% to 18.58%. PBIT margin of Apollo Digital 24/7 segment fell from 1.62% to 0.11%. PBIT margin of others segment rose from negative 227.66% to negative 219.15%. PBIT margin of segment rose from negative 3.68% to negative 1.67%. Overall PBIT margin rose from 8.60% to 8.90%. Operating profit margin has jumped from 12.34% to 12.54%, leading to 16.64% rise in operating profit to Rs 2,390.70 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 13.73% to 12.85%. Purchase of finished goods cost rose from 37.96% to 38.68%. Employee cost decreased from 13.08% to 13.06%. Other expenses fell from 22.91% to 22.88%. Other income rose 17.72% to Rs 106.3 crore. PBIDT rose 16.69% to Rs 2497 crore. Provision for interest rose 18.01% to Rs 449.4 crore. Loan funds rose to Rs 5,332.60 crore as of 31 March 2024 from Rs 4,332.40 crore as of 31 March 2023. Inventories rose to Rs 459.80 crore as of 31 March 2024 from Rs 390.10 crore as of 31 March 2023. Sundry debtors were higher at Rs 2,514.90 crore as of 31 March 2024 compared to Rs 2,234.20 crore as of 31 March 2023. Cash and bank balance rose to Rs 933.80 crore as of 31 March 2024 from Rs 775.80 crore as of 31 March 2023. Investments rose to Rs 986.10 crore as of 31 March 2024 from Rs 573.60 crore as of 31 March 2023 . PBDT rose 16.40% to Rs 2047.6 crore. Provision for depreciation rose 11.63% to Rs 687 crore. Fixed assets increased to Rs 9,524.40 crore as of 31 March 2024 from Rs 8,143.90 crore as of 31 March 2023. Intangible assets increased from Rs 985.80 crore to Rs 1,012.30 crore. Profit before tax grew 18.96% to Rs 1,360.60 crore. Provision for tax was expense of Rs 445.5 crore, compared to Rs 256.2 crore. Effective tax rate was 32.27% compared to 23.28%. Minority interest increased 44.44% to Rs 36.40 crore. Net profit attributable to owners of the company increased 9.71% to Rs 898.60 crore. Equity capital stood at Rs 71.90 crore as of 31 March 2024 to Rs 71.90 crore as of 31 March 2023. Per share face Value remained same at Rs 5.00. Promoters’ stake was 29.33% as of 31 March 2024 ,compared to 29.33% as of 31 March 2023 . Promoters pledged stake was 16.09% as of 31 March 2024 ,compared to 16.63% as of 31 March 2023 . Cash flow from operating activities increased to Rs 1,920.20 crore for year ended March 2024 from Rs 1,376.70 crore for year ended March 2023. Cash flow used in acquiring fixed assets during the year ended March 2024 stood at Rs 1,136.80 crore, compared to Rs 1,128.50 crore during the year ended March 2023. Other Highlights
The company entered into a definitive
agreement to Build and operate a 500-bed hospital to be established in Worli,
Mumbai. The company also announced the expansion of its existing hospital
facility in Lucknow to 500 beds from the present 300 beds by adding another 200
beds, to be developed on their recent acquisition of a 1.2-acre land. With
these two additions, Apollo Hospitals now has plans to add over 3512 total beds
(2877 census beds) over the next 4 years across 11 locations in India.
In Q2 FY25, the company’s Healthcare
Services (HCS) Revenue increased 14% YoY. Apollo HealthCo: Pharmacy
Distribution & Digital Health Revenue grew 17% YoY.
In Q2 FY25, the overall occupancy for
hospitals was at 73% compared to 68% in the same period in the previous year,
aided by a strong increase in patient flows across hospitals.
Apollo HealthCo: Digital Healthcare and
Omni-channel Pharmacy platform added 154 net new stores were in this quarter,
taking the total number to 6,228 stores. The company reported average Q2 FY25
run rate of 76K/day order across Pharma, Diagnostics Consultations (including
IP/OP referrals) compared to 62K/day in Q2 FY24.
Management Comments :
Dr. Prathap C Reddy, Founder &
Chairman, Apollo Hospitals Group said, ·At Apollo Hospitals, we are dedicated
to continually evolving to meet the changing healthcare needs of our nation.
Through strategic initiatives like our investment in Apollo Health and
Lifestyle and the launch of new multi-specialty hospitals, we reaffirm our
commitment to expanding access to high-quality healthcare across India,
particularly in regions where critical care access is essential.
One of our proudest achievements is our
recent partnership with the Government of Tripura to provide free heart
surgeries for children, underscoring our belief that healthcare should reach
those who need it most, especially in underserved communities. Beyond expanding
access, we are advancing medical technology with innovative treatments like
water vapor thermotherapy for prostate care and robotic radiosurgery systems
for cancer. These state-of-the-art solutions make procedures less invasive and
reduce recovery time, resulting in better patient outcomes. We are also
investing in the future of healthcare with the launch of our new research
academy, which is focused on driving groundbreaking medical discoveries that
will shape the next generation of treatments. Our priorities remain clear-enhancing
patient care, prioritizing safety, and advancing medical science.
The first half of FY25 has been an exciting
time for us, marked by these major milestones aimed at extending the reach and
impact of our healthcare services. Moving forward, our mission is simple: to
push the boundaries of healthcare and ensure that everyone, regardless of where
they live, has access to the best medical services. This is our promise, and we
are committed to making it a reality."
| Apollo Hospitals Enterprise : Consolidated Results | | | Quarter ended | Year to Date | Year ended |
|---|
| Particulars | 202409 | 202309 | Var.(%) | 202409 | 202309 | Var.(%) | 202403 | 202303 | Var.(%) |
|---|
| Net Sales (including other operating income) | 5,589.30 | 4,846.90 | 15.32 | 10,674.90 | 9,264.70 | 15.22 | 19,059.20 | 16,612.50 | 14.73 | | OPM (%) | 14.59 | 12.95 | 164 bps | 13.96 | 12.27 | 170 bps | 12.54 | 12.34 | 21 bps | | OP | 815.50 | 627.50 | 29.96 | 1,490.60 | 1,136.50 | 31.16 | 2,390.70 | 2,049.60 | 16.64 | | Other Inc. | 38.20 | 22.20 | 72.07 | 75.40 | 50.40 | 49.60 | 106.30 | 90.30 | 17.72 | | PBIDT | 853.70 | 649.70 | 31.40 | 1,566.00 | 1,186.90 | 31.94 | 2,497.00 | 2,139.90 | 16.69 | | Interest | 117.50 | 111.30 | 5.57 | 233.90 | 217.50 | 7.54 | 449.40 | 380.80 | 18.01 | | PBDT | 736.20 | 538.40 | 36.74 | 1,332.10 | 969.40 | 37.41 | 2,047.60 | 1,759.10 | 16.40 | | Depreciation | 184.5 | 163.4 | 12.91 | 361.9 | 330.3 | 9.57 | 687 | 615.4 | 11.63 | | PBT | 551.70 | 375.00 | 47.12 | 970.2 | 639.1 | 51.81 | 1360.6 | 1143.7 | 18.96 | | Share of Profit/(Loss) from Associates | 5.7 | 2.1 | 171.43 | 17.2 | 8 | 115.00 | 18 | -43.2 | LP | | PBT before EO | 557.4 | 377.1 | 47.81 | 987.4 | 647.1 | 52.59 | 1378.6 | 1100.5 | 25.27 | | EO Income | 0 | 1.9 | - | 0 | 1.9 | - | 1.9 | 0 | - | | PBT after EO | 557.4 | 379 | 47.07 | 987.4 | 649 | 52.14 | 1380.5 | 1100.5 | 25.44 | | Taxation | 161.7 | 130.2 | 24.19 | 276.2 | 226.8 | 21.78 | 445.5 | 256.2 | 73.89 | | PAT | 395.7 | 248.8 | 59.04 | 711.2 | 422.2 | 68.45 | 935 | 844.3 | 10.74 | | Minority Interest (MI) | 16.9 | 15.9 | 6.29 | 27.2 | 22.7 | 19.82 | 36.4 | 25.2 | 44.44 | | Net profit | 378.8 | 232.9 | 62.64 | 684 | 399.5 | 71.21 | 898.6 | 819.1 | 9.71 | | P/(L) from discontinued operations net of tax | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | | Net profit after discontinued operations | 378.8 | 232.9 | 62.64 | 684 | 399.5 | 71.21 | 898.6 | 819.1 | 9.71 | | EPS (Rs)* | 26.35 | 16.12 | 63.46 | 47.57 | 27.70 | 71.71 | 62.41 | 56.97 | 9.56 | | | * EPS is on current equity of Rs 71.89 crore, Face value of Rs 5, Excluding extraordinary items. | | # EPS is not annualised | | bps : Basis points | | EO : Extraordinary items | | Figures in Rs crore | | Source: Capitaline Corporate Database |
|
| Apollo Hospitals Enterprise : Consolidated Segment Results | | | Quarter ended | Year to Date | Year ended |
|---|
| % of (Total) | 202409 | 202309 | Var.(%) | % of (Total) | 202409 | 202309 | Var.(%) | % of (Total) | 202403 | 202303 | Var.(%) |
|---|
| Sales | | Healthcare Services | 52.08 | 2,920.40 | 2,565.90 | 13.82 | 52.04 | 5,574.10 | 4,876.60 | 14.30 | 51.94 | 9,939.20 | 8,743.10 | 13.68 | | Retail Pharmacy | 7.20 | 403.90 | 0.00 | - | | Apollo Digital 24/7 | 40.70 | 2,282.20 | 354.20 | 544.33 | 40.75 | 4,364.30 | 673.00 | 548.48 | 7.13 | 1,364.30 | 1,231.10 | 10.82 | | others | 0.02 | 1.20 | 1.20 | 0 | 0.02 | 2.40 | 2.40 | 0 | 0.02 | 4.70 | 4.70 | 0 | | 40.90 | 7,826.90 | 6,704.50 | 16.74 | | Total Reported Sales | 100.00 | 5,607.70 | 4,866.70 | 15.23 | 100.00 | 10,710.80 | 9,302.80 | 15.14 | 100.00 | 19,135.10 | 16,683.40 | 14.70 | | Less: Inter segment revenues | | 18.40 | 19.80 | -7.07 | | 35.90 | 38.00 | -5.53 | | 75.90 | 70.90 | 7.05 | | Net Sales | 100.00 | 5,589.30 | 4,846.90 | 15.32 | 100.00 | 10,674.90 | 9,264.80 | 15.22 | 100.00 | 19,059.20 | 16,612.50 | 14.73 | | PBIT | | Healthcare Services | 92.12 | 581.30 | 517.90 | 12.24 | 94.93 | 1,071.50 | 940.40 | 13.94 | 108.38 | 1,846.40 | 1,671.40 | 10.47 | | Retail Pharmacy | 1.85 | 11.70 | 0.00 | - | | Apollo Digital 24/7 | 6.16 | 38.90 | 3.00 | 1,196.67 | 4.08 | 46.10 | -7.20 | LP | -0.09 | -1.50 | 20.00 | PL | | others | -0.14 | -0.90 | -5.60 | 83.93 | -0.29 | -3.30 | -7.00 | 52.86 | -0.60 | -10.30 | -10.70 | 3.74 | | -7.68 | -130.90 | -246.50 | 46.90 | | Total PBIT | 100.00 | 631.00 | 464.10 | 35.96 | 100.00 | 1,128.70 | 806.30 | 39.99 | 100.00 | 1,703.70 | 1,434.20 | 18.79 | | Less : Interest | | 117.50 | 111.30 | 5.57 | | 233.90 | 217.50 | 7.54 | | 449.40 | 380.80 | 18.01 | | Add: Other un-allcoable | | 43.90 | 26.20 | 67.56 | | 92.60 | 60.20 | 53.82 | | 126.20 | 47.10 | 167.94 | | PBIT Margin(%) | | Healthcare Services | | 19.90 | 20.18 | -27.91 | | 19.22 | 19.28 | -6.11 | | 18.58 | 19.12 | -53.98 | | Retail Pharmacy | | 2.90 | 0.00 | 289.68 | | 1.87 | 0.00 | 187.01 | | Apollo Digital 24/7 | | 1.70 | 0.85 | 85.75 | | 1.06 | -1.07 | 212.61 | | -0.11 | 1.62 | -173.45 | | others | | -75.00 | -466.67 | 39,166.67 | | -137.50 | -291.67 | 15,416.67 | | -219.15 | -227.66 | 851.06 | | | 0.00 | -3.20 | 319.67 | | -1.67 | -3.68 | 200.42 | | PBT | 100.00 | 557.40 | 379.00 | 47.07 | 100.00 | 987.40 | 649.00 | 52.14 | 100.00 | 1,380.50 | 1,100.50 | 25.44 |
|
|